Edward C Chao
Overview
Explore the profile of Edward C Chao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
354
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chao E, Zhang M, Houle M, Rataj H
J Diabetes Sci Technol
. 2023 Nov;
18(1):14-21.
PMID: 37978817
Background: Acclimating to a new technology device, such as a continuous glucose monitor (CGM), can be challenging. Current resources may not sufficiently answer questions patients living with diabetes (PWD) may...
2.
Chao E
J Diabetes Sci Technol
. 2023 Nov;
18(1):193-195.
PMID: 37970832
Technological advances in devices, such as continuous glucose monitors (CGMs) or intermittently scanned continuous glucose monitors (isCGMs), do not necessarily by themselves translate to improved clinical outcomes or quality of...
3.
Song X, Chao E, Wang C
Biometrics
. 2021 Oct;
79(1):437-448.
PMID: 34694632
We consider the proportional hazards model in which the covariates include the discretized categories of a continuous time-dependent exposure variable measured with error. Naively ignoring the measurement error in the...
4.
de Dieu Tapsoba J, Chao E, Wang C
Int J Biostat
. 2019 Apr;
15(2).
PMID: 30954972
Many biomedical or epidemiological studies often aim to assess the association between the time to an event of interest and some covariates under the Cox proportional hazards model. However, a...
5.
Chao E
Clin Diabetes
. 2015 Aug;
32(1):4-11.
PMID: 26246672
Glucosuria, the presence of glucose in the urine, has long been regarded as a consequence of uncontrolled diabetes. However, glucose excretion can be induced by blocking the activity of the...
6.
Chao E
Core Evid
. 2012 Jun;
7:21-8.
PMID: 22701099
Dapagliflozin is a sodium-glucose co-transporter-2 inhibitor that lowers plasma glucose by decreasing its renal reabsorption. The resulting excretion of glucose in the urine (glucosuria) has transformed what was once solely...
7.
8.
Chao E
Discov Med
. 2011 Mar;
11(58):255-63.
PMID: 21447284
Blocking sodium-glucose cotransporters (SGLTs) to decrease the reabsorption of glucose--and thus increase renal glucose excretion--represents a novel therapeutic approach to diabetes that is independent of insulin secretion or action. Preclinical...
9.
Chao E, Henry R
Nat Rev Drug Discov
. 2010 May;
9(7):551-9.
PMID: 20508640
Inhibiting sodium-glucose co-transporters (SGLTs), which have a key role in the reabsorption of glucose in the kidney, has been proposed as a novel therapeutic strategy for diabetes. Genetic mutations in...
10.
Wang C, Huang Y, Chao E, Jeffcoat M
Biometrics
. 2007 Jul;
64(1):85-95.
PMID: 17608787
Missing data, measurement error, and misclassification are three important problems in many research fields, such as epidemiological studies. It is well known that missing data and measurement error in covariates...